A61F 2/01 Filters implantable into blood vessels
Introduced: January 1995
Last revised: January 2006
Full Title
Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents > Filters implantable into blood vessels
Classification Context
- Section:
- HUMAN NECESSITIES
- Class:
- MEDICAL OR VETERINARY SCIENCE; HYGIENE
- Subclass:
- FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
Filing statistics
IPC A61F 2/01 belongs to the parent subclass A61F, which recorded 447,357 patent applications worldwide between 2013 and 2023. Annual filings grew from 30,362 in 2013 to 39,227 in 2023 (+29%), peaking at 56,342 applications in 2020. The most active applicants in class A61 are PHILIPS ELECTRONICS (18,523 applications), NOVARTIS (14,253 applications) and COVIDIEN (13,953 applications).
Source: EPO PATSTAT, worldwide filings
Related Keywords
Top Applicants
Top 10 applicants by patent filingsfor class A61, 2013–2023, worldwide · Source: EPO PATSTAT
- PHILIPS ELECTRONICS NL 18,523
- NOVARTIS CH 14,253
- COVIDIEN US 13,953
- ROCHE CH 12,005
- CHINESE ACADEMY OF SCIENCES 11,955
- UNIVERSITY OF CALIFORNIA US 11,692
- HARVARD UNIVERSITY US 11,596
- L'OREAL FR 11,593
- P&G (PROCTER & GAMBLE COMPANY) US 11,297
- OLYMPUS CORPORATION JP 9,594